Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.

FDA recently approved Symfi Lo™, a three-drug single-tablet antiretroviral (ARV) regimen, and Cimduo™, a double combination, for HIV treatment Mylan will launch Symfi Lo and Cimduo at a significant discount to the price of competing products to bring co... Biopharmaceuticals, HIV/AIDS, Product Launch Mylan, Symfi Lo, Cimduo, efavirenz, lamivudine, tenofovir
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news